LCE3D promotes inflammatory progression in atopic dermatitis by inhibiting TGF-β1
Archives of Dermatological Research · 30.10.2026 · 318 (1)
DOI: 10.1007/s00403-026-04954-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, online erschienen am 30.10.2026. Verfasst von Dun Liu und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Zhejiang Medicine and Health Research Fund Project, Zhejiang Province Traditional Chinese medicine science and technology project.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory skin disease with a complex pathogenesis. LCE3D, a key functional gene closely related to AD, is associated with TGF-β1, but their roles in AD progression remain unclear. The aim of this study was to investigate the expression of LCE3D and TGF-β1 in AD, as well as the regulatory role of LCE3D on TGF-β1 and influence on cutaneous immune cells. qRT-PCR was performed to detect mRNA levels of LCE3D and TGF-β1 in skin tissues, serum and HaCaT cells. ELISA was performed to detect TGF-β1 content in skin tissues, serum and cell supernatants. Co-immunoprecipitation verified the binding relationship between LCE3D and TGF-β1. A 3D skin model was constructed to simulate the AD microenvironment, and the degree of immune cell infiltration was detected by flow cytometry. The secretion of IL-4, IFN-γ, IL-13, IL-31 and TSLP in the supernatant were determined by ELISA assay. Elevated LCE3D but reduced TGF-β1 expression was found in the lesion tissues and serum of AD patients. Co-immunoprecipitation confirmed the interaction between LCE3D and TGF-β1. LCE3D knockdown significantly decreased LCE3D expression and increased TGF-β1 expression in HaCaT cells, while LCE3D overexpression exhibited the opposite effect. Knockdown of LCE3D also notably promoted IFN-γ secretion, suppressed IL-4, IL-13, IL-31 and TSLP levels, and reduced the percentages of CD45^+ cells. In contrast, LCE3D overexpression significantly inhibited IFN-γ secretion, increased IL-4, IL-13, IL-31 and TSLP levels, and enhanced the percentage of CD45^+ cells, and these phenotypic changes were reversed by TGF-β1 intervention. LCE3D participates in regulating immune cell infiltration and inflammation in AD via modulating TGF-β1, highlighting LCE3D may serve as a promising therapeutic target for AD. Graphical abstract
Förderung
- Zhejiang Medicine and Health Research Fund Project
- Zhejiang Province Traditional Chinese medicine science and technology project
Zitieren
APA
Liu, D., Wang, Z., Jia, X., You, J., & Shen, L. (2026). LCE3D promotes inflammatory progression in atopic dermatitis by inhibiting TGF-β1. Archives of Dermatological Research, 318(1). https://doi.org/10.1007/s00403-026-04954-4
Vancouver
Liu D, Wang Z, Jia X, You J, Shen L. LCE3D promotes inflammatory progression in atopic dermatitis by inhibiting TGF-β1. Archives of Dermatological Research. 2026;318(1). doi:10.1007/s00403-026-04954-4
BibTeX
@article{Liu2026,
author = {Liu, Dun and Wang, Zhongyun and Jia, Xiaoxiao and You, Jianhua and Shen, Liling},
title = {LCE3D promotes inflammatory progression in atopic dermatitis by inhibiting TGF-β1},
journal = {Archives of Dermatological Research},
year = {2026},
volume = {318},
number = {1},
doi = {10.1007/s00403-026-04954-4}
}
EUVIMED